Digest Network Come funziona
Network
/
Società
Mi
Non verificato

MindWalk Holdings Corp.

Di cosa scriviamo

BiotecnologiaFarmaceuticaHIV, AIDS e malattie autoimmuniSaluteTecnica

15 comunicati stampa

Guarda tutti i comunicati
06/03/2026
Industria
Tecnica
Biotecnologia
Tecnologie Varie
Salute
Farmaceutica
Oncologia
Scienza
HIV, AIDS e malattie autoimmuni
Medicina - Varie
MindWalk Announces B Cell Llama™, a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
02/03/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Scienza
Biotecnologia
Salute
HIV, AIDS e malattie autoimmuni
Tecnica
MindWalk Holdings Corp. to Report Third Quarter Fiscal Year 2026 Financial Results on March 12, 2026
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
27/01/2026
Software
Scienza
Sanità
Hardware informatico
Farmaceutica
Tecnica
HIV, AIDS e malattie autoimmuni
Biotecnologia
Tecnologie Varie
Salute
Industria
MindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
14/01/2026
Scienza
Software
Farmaceutica
Salute
HIV, AIDS e malattie autoimmuni
Tecnica
Industria
MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
12/01/2026
Biotecnologia
Tecnica
Associazioni/Professionisti
Salute
Farmaceutica
Scienza
HIV, AIDS e malattie autoimmuni
Software
Industria
REPEAT/MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
10/01/2026
Industria
Biotecnologia
Tecnica
Associazioni/Professionisti
Salute
Farmaceutica
Scienza
HIV, AIDS e malattie autoimmuni
Software
MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
15/12/2025
Web e Social Network
Telefonia e Varie
Mercato azionario
Tecnica
Scienza
HIV, AIDS e malattie autoimmuni
Software
Biotecnologia
Salute
Farmaceutica
MindWalk Reports Record Growth and Announces Strategic Progress on Its AI Asset Pipeline
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
08/12/2025
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Tecnica
Scienza
HIV, AIDS e malattie autoimmuni
Software
Biotecnologia
Salute
Farmaceutica
MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2026 on December 15, 2025
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
13/11/2025
Salute
Tecnica
HIV, AIDS e malattie autoimmuni
Farmaceutica
Biotecnologia
Eventi
Fiere
MindWalk CTO Dr. Dirk Van Hyfte to Join Fireside Chat at AI Drug Discovery & Development Summit 2025
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0
21/10/2025
Software
Scienza
Farmaceutica
Information Technology
Tecnica
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Biotecnologia
Salute
Mercato del lavoro
MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy
Fonte
MindWalk Holdings Corp.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0